The pharmacokinetics of losartan in renal insufficiency

Journal of Hypertension, Supplement

Volumn 13, Issue 1, 1995, Pages

  Sica, D A ^a   Lo, M W ^a   Shaw, W C ^a   Keane, W F ^a   Gehr, T W B ^a   Halstenson, C E ^a   Lipschutz, K ^a   Furtek, C I ^a   Ritter, M A ^a   Shahinfar, S ^a  

^a Clinical Pharmacology and Hypertension   (United States)

Author keywords

Angiotensin II; Angiotensin II receptor antagonist; Blood pressure; E3174; Plasma drug levels; Renal failure

Indexed keywords

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; DRUG METABOLITE; LOSARTAN; LOSARTAN POTASSIUM;

ADULT; AREA UNDER THE CURVE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CREATININE CLEARANCE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG URINE LEVEL; FEMALE; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PULSE RATE;

ADULT; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; BLOOD PRESSURE; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; IMIDAZOLES; LOSARTAN; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; TETRAZOLES;

EID: 0029096977     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)